Search

Eurofins Scientific SE

Geschlossen

67.68 0.3

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

67.02

Max

67.82

Schlüsselkennzahlen

By Trading Economics

Einkommen

105M

228M

Verkäufe

1.9B

3.7B

KGV

Branchendurchschnitt

29.612

25.238

Dividendenrendite

1.06

Gewinnspanne

6.2

Angestellte

65,000

EBITDA

285M

693M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+9.24% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.06%

4.00%

Nächstes Ergebnis

25. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-643M

12B

Vorheriger Eröffnungskurs

67.38

Vorheriger Schlusskurs

67.68

Technischer Score

By Trading Central

Vertrauen

Weak Bearish Evidence

Eurofins Scientific SE Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

10. Feb. 2026, 23:26 UTC

Wichtige Markttreiber

Moderna Stock Slips After FDA Refuses Flu Vaccine Review

10. Feb. 2026, 22:31 UTC

Ergebnisse

Correction to America Movil 4Q Profit Article

10. Feb. 2026, 22:22 UTC

Ergebnisse

America Movil 4Q Profit Jumps on Lower Financial Costs

10. Feb. 2026, 23:51 UTC

Market Talk
Ergebnisse

Commonwealth Bank's Margin Management Gives It a Platform -- Market Talk

10. Feb. 2026, 23:42 UTC

Market Talk

Gold Rises Amid Fed Rate-Cut Prospects -- Market Talk

10. Feb. 2026, 23:40 UTC

Market Talk
Ergebnisse

Commonwealth Bank Bear Says 1H Result Looks Strong -- Market Talk

10. Feb. 2026, 23:21 UTC

Market Talk

Ford Says EV Shift Was Driven by Demand Changes -- Market Talk

10. Feb. 2026, 23:21 UTC

Market Talk

Global Equities Roundup: Market Talk

10. Feb. 2026, 22:17 UTC

Market Talk

Australia's One Nation Now Commands Working Class Vote -- Market Talk

10. Feb. 2026, 22:15 UTC

Ergebnisse

Humana Earnings Will Shed More Light on Medicare Prospects -- Barrons.com

10. Feb. 2026, 22:10 UTC

Ergebnisse

Intact Financial 4Q Book Value Per Share Was C$107.35 >IFC.T

10. Feb. 2026, 22:10 UTC

Ergebnisse

Intact Financial Raises Qtr Dividend to C$1.47 >IFC.T

10. Feb. 2026, 22:09 UTC

Ergebnisse

Intact Financial 4Q Combined Ratio Was 85.9% >IFC.T

10. Feb. 2026, 22:09 UTC

Ergebnisse

Intact Financial 4Q Adj EPS C$5.50 >IFC.T

10. Feb. 2026, 22:01 UTC

Ergebnisse

Intact Financial 4Q EPS C$5.24 >IFC.T

10. Feb. 2026, 21:54 UTC

Ergebnisse

James Hardie Industries Sees FY26 Total Adjusted EBITDA $1.232B to $1.263B >JHX

10. Feb. 2026, 21:53 UTC

Ergebnisse

Robinhood Stock Tumbles as Crypto-Related Revenue Falls Short of Expectations -- Barrons.com

10. Feb. 2026, 21:51 UTC

Ergebnisse

James Hardie Industries Sees FY26 Free Cash Flow at Least $200M

10. Feb. 2026, 21:51 UTC

Ergebnisse

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10. Feb. 2026, 21:51 UTC

Ergebnisse

James Hardie Industries: Focused on the Achievement of $125 M Target >JHX

10. Feb. 2026, 21:51 UTC

Ergebnisse

James Hardie Industries: Integration and Cost Synergies Ahead of Schedule >JHX

10. Feb. 2026, 21:51 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Evolution Net Debt A$362 Million at Dec. 31 Vs A$1.29 Billion Year Earlier

10. Feb. 2026, 21:50 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Evolution: Gearing 6% at Dec. 31, From 23% a Year Earlier

10. Feb. 2026, 21:50 UTC

Ergebnisse

James Hardie Industries 3Q EPS 12c >JHX

10. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10. Feb. 2026, 21:50 UTC

Ergebnisse

James Hardie Industries 3Q Adj EPS 24c >JHX

10. Feb. 2026, 21:49 UTC

Ergebnisse

James Hardie Industries 3Q Sales $1.24B >JHX

10. Feb. 2026, 21:49 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Evolution 1H Operating Mine Cash Flow a Record A$1.73 Billion

10. Feb. 2026, 21:48 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Evolution 1H Ebitda A$1.56 Billion, Up 59% On-Year

10. Feb. 2026, 21:47 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Evolution 1H Revenue A$2.79 Billion, Up 37% On-Year

Eurofins Scientific SE Prognose

Kursziel

By TipRanks

9.24% Vorteil

12-Monats-Prognose

Durchschnitt 73.43 EUR  9.24%

Hoch 81 EUR

Tief 64 EUR

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Eurofins Scientific SE – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

4 ratings

2

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

54.22 / 56.82Unterstützung & Widerstand

Kurzfristig

Weak Bearish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Bullish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
help-icon Live chat